Jinan Babio Biotechnology Co., Ltd.

was established in 2003 and is a high-tech enterprise specializing in the research, development, production and sales of in vitro diagnostic reagents. The company was successfully listed on the NEEQ on May 30, 2014 (stock name: Babio, stock code: 830774), becoming the first domestic in vitro diagnostic reagent listed company after the expansion of the NEEQ. The company has established a strict quality management system and passed the ISO9001:2008 and ISO13485:2003 international quality system certification.

It has the current international advanced automatic production equipment, and the workshop strictly follows Standard design, and reach ten thousand purification standards.Babio Biotech is strong in technology and currently owns 37 independent intellectual property rights, including 2 invention patents, and undertakes a number of provincial and municipal scientific and technological innovation projects. Products mainly involve microbiology / clinical test reagents, medical equipment / robots, biochemical.